Technology’s Role In Advancing Outcomes & Reducing The Cost Of Care For The SMI Population is starting in

SAMHSA Notice To Opioid Treatment Programs About Drug Enforcement Administration Authorization For Mobile Components

On September 29, 2021, the U.S. Substance Abuse and Mental Health Ervices Administration (SAMHSA) published this notice to opioid treatment programs about Drug Enforcement Administration (DEA) authorization for mobile components. This document revises and supersedes related portions of SAMHSA’s 2015 Federal Guidelines for Opioid Treatment Programs (Guidelines) by clarifying the range of services that can be provided in both mobile and non-mobile medication units . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.